Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pasithea Therapeutics Corp.

1.73
+0.01000.58%
Volume:171.18K
Turnover:288.57K
Market Cap:4.68M
PE:-0.14
High:1.76
Open:1.76
Low:1.60
Close:1.72
Loading ...
Sep 14, 2023

Major Issues Report

Form 8-K - Current report
Aug 22, 2023

Correspondence

Form CORRESP - Correspondence
Aug 12, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 20, 2023

Major Issues Report

Form 8-K - Current report
Jul 20, 2023

Major Issues Report

Form 8-K - Current report
Jun 08, 2023

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Jun 01, 2023

Correspondence

Form CORRESP - Correspondence
May 12, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 17, 2023

Correspondence

Form CORRESP - Correspondence
Apr 04, 2023

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 30, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 30, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 10, 2023

Major Issues Report

8-K - Current report
Feb 15, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 24, 2023

Major Issues Report

8-K - Current report
Jan 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 10, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Dec 14, 2022

Major Issues Report

8-K - Current report
Dec 14, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 14, 2022

Correspondence

CORRESP [Cover] - Correspondence